Agreed, a lot of the earnings uplift came from some prices increases and GP margin expansion from new products, as well as cost inflation coming out of their inventory.
Having said that, the growth rate is more or less in line with historical standards, and this even after the abnormal uplift from Covid and Philips leaving the industry. The fact they have continuted to be able to grow off that base is frankly incredible. I'll take a 10% topline growth rate any day of the week in this environment.
Interestingly, their SaaS revenue is growing faster then previous years, and continues to become a much larger part of their total revenue.
24.3% last year, and another 17.3% on top of that this year.
- Forums
- ASX - By Stock
- RMD
- Why the drop?
Why the drop?, page-85
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.04 |
Change
-0.620(1.69%) |
Mkt cap ! $22.01B |
Open | High | Low | Value | Volume |
$35.95 | $36.08 | $35.49 | $58.29M | 1.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27 | $35.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.05 | 12289 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27 | 35.960 |
1 | 15 | 35.950 |
1 | 576 | 35.940 |
1 | 750 | 35.900 |
1 | 19 | 35.810 |
Price($) | Vol. | No. |
---|---|---|
36.050 | 200 | 1 |
36.060 | 700 | 1 |
36.100 | 549 | 2 |
36.500 | 200 | 1 |
36.570 | 280 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online